The Centers for Medicare & Medicaid Services yesterday released a request for applications to participate in the Part D Payment Modernization Model in calendar year 2022.

The five-year model, which began this month, will test new incentives for Medicare prescription drug plans, patients and providers to choose drugs with lower list prices. For CY 2022, CMS said the model will test new flexibilities to better align Part D formularies with other pharmacy benefit designs in the commercial and individual markets, and remove the model’s downside risk.

Interested Part D sponsors should submit a non-binding notice of intent to apply by March 1 and an application by April 16, 2021.

Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Blog
Public
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services released a proposed rule June 12 seeking to codify the…
Headline
The Medicare Payment Advisory Commission June 15 released its June report to Congress that estimated the association between Medicare Advantage enrollment and…
Headline
The Centers for Medicare & Medicaid Services June 12 issued a final rule revising how the agency conducts oversight of accrediting organizations that…
Headline
The Department of Health and Human Services Office of Inspector General June 11 released two reports on high rates of coverage denials by Medicare Advantage…